Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events

World Journal of Gastroenterology

Volumn 15, Issue 8, 2009, Pages 927-935

  Wang, Jennifer Y ^a   Terdiman, Jonathan P ^a   Vittinghoff, Eric ^a   Minichiello, Tracy ^a   Varma, Madhulika G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hospitalized patients; Thromboembolism; Ulcerative colitis

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; ARTERY EMBOLISM; ARTICLE; CEREBROVASCULAR ACCIDENT; COLON RESECTION; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIVERTICULITIS; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; THROMBOEMBOLISM; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM; AGED; COLORECTAL TUMOR; HEART ATRIUM FIBRILLATION; LENGTH OF STAY; MIDDLE AGED; OBESITY; PROBABILITY; RISK FACTOR; STROKE; SURVIVAL; SURVIVOR; VEIN THROMBOSIS;

AGED; ATRIAL FIBRILLATION; COLECTOMY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MIDDLE AGED; OBESITY; PROBABILITY; PULMONARY EMBOLISM; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; SURVIVORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 65649108926     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.927     Document Type: Article

References (32)

1. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23-29
2. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85: 430-434
3. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar J, Machold K, Scholz S, Vogelsang H, Novacek G. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-548
4. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145
5. National Hospital Discharge Survey Multi-year Data File 1979-2003 [CD-ROM]. Hyattsville, MD: US Dept of Health and Human Services, Center for Disease Control and Prevention, National Center for Health Statistics, 2001; 13: 19A
6. Buck CJ, Lockyer KD. Saunders2007ICD-9-CM Volumes 1, 2, & 3. Louis: WB Saunders, 2006
7. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 2003; 14: 341-346
8. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-3420
9. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938
10. Remzi FH, Fazio VW, Oncel M, Baker ME, Church JM, Ooi BS, Connor JT, Preen M, Einstein D. Portal vein thrombi after restorative proctocolectomy. Surgery 2002; 132: 655-661; discussion 661-662
11. Fichera A, Cicchiello LA, Mendelson DS, Greenstein AJ, Heimann TM. Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain. Dis Colon Rectum 2003; 46: 643-648
12. Novacek G, Haumer M, Schima W, Muller C, Miehsler W, Polterauer P, Vogelsang H. Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. Inflamm Bowel Dis 2004; 10: 430-435
13. Schneiderman JH, Sharpe JA, Sutton DM. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 1979; 5: 331-337
14. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol 2007; 102: 174-186
15. Guedon C, Le Cam-Duchez V, Lalaude O, Menard JF, Lerebours E, Borg JY. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1448-1454
16. Mahmud N, Molloy A, McPartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG. Increased prevalence of methylene tetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 1999; 45: 389-394
17. Aichbichler BW, Petritsch W, Reicht GA, Wenzl HH, Eherer AJ, Hinterleitner TA, Auer-Grumbach P, Krejs GJ. Anti-cardiolipin antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1999; 44: 852-856
18. Koutroubakis IE, Petinaki E, Anagnostopoulou E, Kritikos H, Mouzas IA, Kouroumalis EA, Manousos ON. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1998; 43: 2507-2512
19. Attvall E, Frigyesi A, Sternby B. What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease? Int J Colorectal Dis 2006; 21: 705-710
20. Panes J, Esteve M, Cabre E, Hinojosa J, Andreu M, Sans M, Fernandez-Banares F, Feu F, Gassull MA, Pique JM. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology 2000; 119: 903-908
21. Ang YS, Mahmud N, White B, Byrne M, Kelly A, Lawler M, McDonald GS, Smith OP, Keeling PW. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14: 1015-1022
22. Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther 2006; 23: 1443-1453
23. Bloom S, Kiilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, Irvine EJ, O'Morain C, Lowson D, Orm S. Low molecular weight heparin (tinzaparin) vs placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 871-878
24. Turpie AG. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial. Am J Cardiol 2000; 86: 48M-52M
25. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99: 97-101
26. Sonoda K, Ikeda S, Mizuta Y, Miyahara Y, Kohno S. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease. J Gastroenterol 2004; 39: 948-954
27. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994; 32: 81-90
28. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119: 60-68
29. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118: 978-980
30. Stein PD, Hull RD, Kayali F, Ghali WA, Alshab AK, Olson RE. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 2004; 164: 2260-2265
31. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Alshab AK, Meyers FA. Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med 2003; 163: 1843-1848
32. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 2005; 96: 1731-1733